Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

enVVeno Medical Corporation - Common Stock (NQ:NVNO)

9.398 +0.048 (+0.51%)
Streaming Delayed Price Updated: 11:38 AM EST, Feb 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about enVVeno Medical Corporation - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
enVVeno Medical Highlights Successful 2024 VEITH Symposium with Launch of Recap Website
Via ACCESSWIRE
News headline image
enVVeno Medical to Present Definitive One Year Data from the VenoValve U.S. Pivotal Trial Today at the 51st Annual VEITH Symposium
Via ACCESSWIRE
News headline image
enVVeno Medical Submits the VenoValve PMA Application Seeking FDA Approval
Via ACCESSWIRE
News headline image
enVVeno Medical Reports Third Quarter 2024 Financial Results and Confirms Guidance for Release of Definitive VenoValve Data in November and Completion of FDA Premarket Approval Application for VenoValve in Q4 of this Year
Via ACCESSWIRE
News headline image
enVVeno Medical Successfully Initiates 6-Month Pre-Clinical GLP Study Evaluating enVVe(R)
Via ACCESSWIRE
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
enVVeno Medical Adds Sandy Prietto to its Executive Team as Vice President of Marketing
Via ACCESSWIRE
News headline image
enVVeno Medical Provides Update on FDA Premarket Approval Application Status for VenoValve(R)
Via ACCESSWIRE
News headline image
enVVeno Medical Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Via ACCESSWIRE
News headline image
enVVeno Medical to Participate in the Virtual Investor Closing Bell Series
Via ACCESSWIRE
BioMedNewsBreaks — enVVeno Medical Corporation (NASDAQ: NVNO) Announces Pricing of $15M Underwritten Public Offering
Via Investor Brand Network
News headline image
Crude Oil Rises; Onconetix Shares Spike Higher ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Nasdaq Moves Lower; Fed's Preferred Inflation Gauge Falls More Than Projected ↗
 
Via Benzinga
Topics Economy
News headline image
Dow Surges Over 100 Points; Costco Earnings Top Views ↗
 
Via Benzinga
Topics Stocks
News headline image
enVVeno Medical Appoints Andrew Cormack as Its Chief Commercial Officer
Via ACCESSWIRE
News headline image
enVVeno Medical to Participate in the Virtual Investor Lunch Break: The enVVeno Opportunity
Via ACCESSWIRE
News headline image
Cassava Sciences, enVVeno Medical And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Establishment Labs Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Costco, Scholastic And 3 Stocks To Watch Heading Into Friday ↗
 
Via Benzinga
News headline image
enVVeno Medical Corporation Announces Pricing of $15.0 Million Public Offering
Via ACCESSWIRE
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
enVVeno Medical Corporation Announces Proposed Public Offering
Via ACCESSWIRE
News headline image
Positive Interim Venous Ulcer Healing Data Showing Significant Improvement from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented Today at the Society for Vascular Surgery 2024 Vascular Annual Meeting
Via ACCESSWIRE
News headline image
New Interim Venous Ulcer Healing Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the Society for Vascular Surgery 2024 Vascular Annual Meeting on June 21, 2024
Via ACCESSWIRE
News headline image
NVNO Stock Earnings: enVVeno Medical Beats EPS for Q1 2024 ↗
NVNO stock results show that enVVeno Medical beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
News headline image
enVVeno Medical Reports First Quarter 2024 Financial Results and Provides Corporate Update
Via ACCESSWIRE
News headline image
Positive 11 Month Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical's VenoValve(R) Pivotal Trial to be Presented Today at the 46th Annual Charing Cross Symposium
Via ACCESSWIRE
News headline image
Positive Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical’s VenoValve(R) Pivotal Trial to be Presented Today at the VENOUS2024 American Venous Forum Annual Meeting
Via ACCESSWIRE
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.